Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges

por Packard, Chris, Chapman, M John, Sibartie, Mahendra, Laufs, Ulrich, Masana, Luis
Publicado 2021

Low-density lipoprotein cholesterol levels exceed the recommended European threshold for PCSK9i initiation: lessons from the HEYMANS study

por Ray, Kausik K, Dhalwani, Nafeesa, Sibartie, Mahendra, Bridges, Ian, Ebenbichler, Christoph, Perrone-Filardi, Pasquale, Villa, Guillermo, Vogt, Anja, Bruckert, Eric
Publicado 2022

Cost-effectiveness of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab in patients with a history of myocardial infarction in Sweden

por Landmesser, Ulf, Lindgren, Peter, Hagström, Emil, van Hout, Ben, Villa, Guillermo, Pemberton-Ross, Peter, Arellano, Jorge, Svensson, Maria Eriksson, Sibartie, Mahendra, Fonarow, Gregg C
Publicado 2020